Clinical Trial

« Back to List

MM 23

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: August 01, 2011

Status: ON HOLD - IIT
Research Hotline: 803-461-3708

Details: Phase II Study for the Evaluation of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of patients with Multiple Myeloma Who are not Candidates for High Dose Chemotherapy.

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share